Compagnie Lombard Odier SCmA’s Scopus BioPharma Inc. Common Stock SCPS Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio SCPS Stock Details SCPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,360	Closed	-$1K	–	721
2022 Q3	$1K	Hold	4,360	–	–	﹤0.01%	628
2022 Q2	$2K	Hold	4,360	–	–	﹤0.01%	588
2022 Q1	$3K	Hold	4,360	–	–	﹤0.01%	583
2021 Q4	$7K	Hold	4,360	–	–	﹤0.01%	639
2021 Q3	$18K	Buy	+4,360	New	+$22.4K	﹤0.01%	573

Other funds holding SCPS

MRCM

M&R Capital Management Summit, New Jersey $454M AUM 40.11% 1-Year Est. Return

Compagnie Lombard Odier SCmA's SCPS Position: Q4 2022 in Review

Compagnie Lombard Odier SCmA sold out of Scopus BioPharma Inc. Common Stock (SCPS) in Q4 2022, closing a stake of 4,360 shares — an estimated $1K sold.

Compagnie Lombard Odier SCmA first reported a position in SCPS in Q3 2021 and held it in 5 quarters. The position peaked at $18K in Q3 2021. 1 fund tracked by Wall St. Rank holds SCPS as of Q4 2022.

Compagnie Lombard Odier SCmA reported no remaining Scopus BioPharma Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Compagnie Lombard Odier SCmA sold 4,360 Scopus BioPharma Inc. Common Stock shares in Q4 2022, an estimated $1K.
Compagnie Lombard Odier SCmA first reported a position in Scopus BioPharma Inc. Common Stock in Q3 2021 and held it in 5 quarters.
Compagnie Lombard Odier SCmA's Scopus BioPharma Inc. Common Stock position peaked at $18K in Q3 2021.
1 fund tracked by Wall St. Rank held Scopus BioPharma Inc. Common Stock as of Q4 2022.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q4 2022, filed 13 Feb 2023.